Search: celline_specificity_rna:Hep G2;Group enriched - The Human Protein Atlas

We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.

110 GENES FOUND

Show / hide columns »

XML | RDF | TAB | Page of 3 | next »

Gene

Gene description	x

Protein class	x

Tissue

Cell

Cancer

Subcellular location	x

RNA tissue category	x

A1CF

APOBEC1 complementation factor

Predicted intracellular proteins

Tissue enhanced

Aldo-keto reductase family 1, member B10 (aldose reductase)

Predicted intracellular proteins

Plasma membrane
Cytosol

Tissue enhanced

Ankyrin repeat and sterile alpha motif domain containing 4B

Predicted intracellular proteins

Nucleoplasm
Cytosol

Tissue enhanced

Apolipoprotein C-III

Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Plasma proteins
Predicted secreted proteins

Tissue enriched

Complement component 4 binding protein, beta

Plasma proteins
Predicted secreted proteins

Cytokine receptor-like factor 1

Disease related genes
Predicted intracellular proteins
Predicted secreted proteins

Tissue enhanced

Cytochrome P450, family 24, subfamily A, polypeptide 1

Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins

Nucleoplasm
Plasma membrane
Mitochondria

Tissue enhanced

Cytochrome P450, family 2, subfamily W, polypeptide 1

Predicted intracellular proteins
Predicted secreted proteins

Tissue enhanced

Cytochrome P450, family 4, subfamily F, polypeptide 3

Enzymes
Predicted intracellular proteins
Predicted membrane proteins

Tissue enhanced

EPO

Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Predicted secreted proteins

Tissue enhanced

Predicted intracellular proteins

Coagulation factor VII (serum prothrombin conversion accelerator)

Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins

Tissue enriched

Fatty acid binding protein 1, liver

Cancer-related genes
Plasma proteins
Predicted intracellular proteins

Nucleoplasm
Cytosol

FGL1

Fibrinogen-like 1

Plasma proteins
Predicted secreted proteins

Tissue enriched

Glutathione S-transferase alpha 2

Enzymes
Predicted intracellular proteins

HLF

Hepatic leukemia factor

Cancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors

HNF1 homeobox A

Cancer-related genes
Predicted intracellular proteins

Tissue enhanced

Hepatocyte nuclear factor 4, alpha

Disease related genes
Nuclear receptors
Predicted intracellular proteins
Transcription factors

ISX

Intestine-specific homeobox

Predicted intracellular proteins
Transcription factors

Nucleoplasm
Nuclear bodies

Lectin, galactoside-binding, soluble, 2

Predicted intracellular proteins

Nucleoplasm
Mitochondria

Tissue enhanced

Phospholipase A2, group XIIB

Plasma proteins
Predicted secreted proteins
RAS pathway related proteins

RGN

Enzymes
Plasma proteins
Predicted intracellular proteins

Tissue enhanced

Sodium channel, voltage gated, type I alpha subunit

Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels

Nucleoplasm
Nuclear bodies
Plasma membrane

Tissue enhanced

Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4

Plasma proteins
Predicted secreted proteins

Tissue enhanced

Solute carrier family 26 (anion exchanger), member 9

Predicted membrane proteins
Transporters

Nucleus
Cell Junctions

Tissue enhanced

Solute carrier family 2 (facilitated glucose transporter), member 2

Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters

Tissue enriched

Solute carrier family 39 (zinc transporter), member 4

Disease related genes
Predicted membrane proteins
Predicted secreted proteins

Solute carrier family 39 (zinc transporter), member 5

Disease related genes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters

Nucleoplasm
Vesicles
Cytosol

Solute carrier family 51, beta subunit

Predicted membrane proteins
Transporters

Vesicles
Mitochondria

Tissue enhanced

Solute carrier family 6 (neurotransmitter transporter), member 4

FDA approved drug targets
Predicted membrane proteins
Transporters

Golgi apparatus
Vesicles

Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9

Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters

SP5

Sp5 transcription factor

Predicted intracellular proteins
Transcription factors

Nucleus
Nucleoli

Tissue enhanced

Transmembrane 4 L six family member 5

Predicted membrane proteins

Nucleoplasm
Plasma membrane
Cell Junctions

VIL1

Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins

Plasma membrane

A2M

Alpha-2-macroglobulin

Cancer-related genes
Candidate cardiovascular disease genes
Plasma proteins
Predicted secreted proteins

Expressed in all

ADH6

Alcohol dehydrogenase 6 (class V)

Enzymes
Predicted intracellular proteins

Tissue enriched

Aldo-keto reductase family 1, member B15

Enzymes
Predicted intracellular proteins

Plasma membrane
Cytosol

Tissue enriched

Ankyrin repeat domain 65

Predicted intracellular proteins

Tissue enhanced

Chromosome 19 open reading frame 80

Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins

Nucleoplasm
Golgi apparatus

Chromosome 1 open reading frame 64

Predicted intracellular proteins

Tissue enhanced

Complement component 2

Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted secreted proteins

Tissue enhanced

Complement component 3

Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins

Expressed in all

CD7

CD markers
Predicted membrane proteins
Predicted secreted proteins

Tissue enhanced

CES1

Carboxylesterase 1

Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins

Endoplasmic reticulum

Carbohydrate (chondroitin 4) sulfotransferase 13

Enzymes
Predicted secreted proteins

Tissue enhanced

Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9

Predicted intracellular proteins
Predicted membrane proteins

Tissue enhanced

Creatine kinase, mitochondrial 2 (sarcomeric)

Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins

Collagen, type IX, alpha 3

Disease related genes
Predicted intracellular proteins
Predicted secreted proteins

Nucleoplasm
Intermediate filaments

CPE

Carboxypeptidase E

Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins

Nucleoplasm
Vesicles
Centrosome

Expressed in all

Predicted intracellular proteins

Tissue enhanced

Page of 3 | next »

Contact

contact@proteinatlas.org

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.